Evaluation of primary androgen deprivation therapy in prostate cancer patients using the J-CAPRA risk score

PURPOSE: To determine the influence of maximal androgen blockade (MAB) and non-MAB hormonal therapy with an luteinizing hormone releasing hormone (LHRH) analog on overall survival of prostate cancer patients in the Japan Study Group of Prostate Cancer (J-CaP) registry according to risk, as assessed...

Descripción completa

Detalles Bibliográficos
Autores principales: Akaza, Hideyuki, Hinotsu, Shiro, Usami, Michiyuki, Ogawa, Osamu, Kitamura, Tadaichi, Suzuki, Kazuhiro, Tsukamoto, Taiji, Naito, Seiji, Namiki, Mikio, Hirao, Yoshihiko, Murai, Masaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society (APPS) 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814111/
https://www.ncbi.nlm.nih.gov/pubmed/24223407
http://dx.doi.org/10.12954/PI.12016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814111/
https://www.ncbi.nlm.nih.gov/pubmed/24223407
http://dx.doi.org/10.12954/PI.12016

Ejemplares similares